As a matter of fact, with the class II HLA-DRB1*1501 allele conferring a ~3-fold risk increase [as measured by the odds ratio (OR)], the MHC region still represents the most important MS risk locus by far (6). Here, HLA-DRB1 is linked to myeloid sarcoma.